EXHIBIT 11. STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE
(Unaudited)
Eli Lilly and Company and Subsidiaries
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
(Dollars and shares in millions except per-share data) | ||||||||||||||||
BASIC | ||||||||||||||||
Net income | $ | 958.8 | $ | 663.6 | $ | 2,023.1 | $ | 1,172.3 | ||||||||
Average number of common shares outstanding | 1,092.1 | 1,089.0 | 1,091.8 | 1,088.7 | ||||||||||||
Contingently issuable shares | 1.7 | .6 | 2.0 | 1.0 | ||||||||||||
Adjusted average shares | 1,093.8 | 1,089.6 | 1,093.8 | 1,089.7 | ||||||||||||
Basic earnings per share | $ | .88 | $ | .61 | $ | 1.85 | $ | 1.08 | ||||||||
DILUTED | ||||||||||||||||
Net income | $ | 958.8 | $ | 663.6 | $ | 2,023.1 | $ | 1,172.3 | ||||||||
Average number of common shares outstanding | 1,092.1 | 1,089.0 | 1,091.8 | 1,088.7 | ||||||||||||
Incremental shares — stock options and contingently issuable shares | 1.7 | .9 | 2.2 | 1.2 | ||||||||||||
Adjusted average shares | 1,093.8 | 1,089.9 | 1,094.0 | 1,089.9 | ||||||||||||
Diluted earnings per share | $ | .88 | $ | .61 | $ | 1.85 | $ | 1.08 | ||||||||